Zymeworks, Inc. (ZYME)
24.17
+0.24
(+1.00%)
USD |
NASDAQ |
May 18, 14:46
Zymeworks Shareholders Equity (Quarterly) : 163.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.277B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Vertex Pharmaceuticals, Inc. | 19.36B |
| AbbVie, Inc. | -6.656B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.22M |
| Total Liabilities (Quarterly) | 314.63M |
| Debt to Equity Ratio | 1.611 |
| Current Ratio | 10.82 |
| Net Debt Paydown Yield | -2.66% |